Market Cap: $109.1M
MI
Minerva Neurosciences, Inc.
NERV
NASDAQ (NASDAQ Global Market)USD
Market Cap: $109.1M
Advancing Neurodiagnostic Capabilities through Strategic Partnerships Aidoc, a leader in clinical AI technology, forges strategic partnerships with Cercare Medical and Circle CVI to enhance its neuros…
Neurvati Neurosciences Strengthens Leadership with Appointment of Chief Commercial Officer Neurvati Neurosciences, a subsidiary of Blackstone Life Sciences, announces the appointment of Carlos Martin…
Neurvati Neurosciences Strengthens Leadership with Appointment of Carlos Martin as Chief Commercial Officer Neurvati Neurosciences, a prominent player in the biopharmaceutical sector, announces the ap…
NewcelX Appoints Renowned Neurologist to Scientific Advisory Board, Enhancing Its Commitment to Neurodegenerative Disease Therapies NewcelX Ltd., a Zurich-based biotechnology firm, strengthens its Sci…
NewcelX Strengthens Scientific Advisory Board with Neurologist Expertise On November 6, 2025, NewcelX Ltd., a biotechnology firm based in Zurich, Switzerland, announces the appointment of Professor Ta…
Minerva Neurosciences Advances Schizophrenia Treatment with New Funding Minerva Neurosciences Inc. announces a significant step in its quest to develop innovative treatments for schizophrenia with the…
Klotho Neurosciences Expands Focus on Regenerative Medicine through Strategic Acquisition In a significant move within the biotechnology sector, Klotho Neurosciences, Inc. has signed a Letter of Inten…
Klotho Neurosciences Pioneers Future of Neurodegenerative Disease Therapies Klotho Neurosciences, Inc. is set to make significant strides in the biotechnology sector, specifically in the realm of neur…
### Klotho Neurosciences Pioneers Neurodegenerative Disease Therapies at Inaugural Conference Klotho Neurosciences, Inc. is positioned to make significant strides in the field of neurodegenerative dis…
Innovative Focus on Klotho-based Therapeutics in Neurodegenerative Disease Treatment Klotho Neurosciences, Inc., a biotechnology company dedicated to developing Klotho-based therapeutics, is poised to…
Klotho Neurosciences Partners with AAVnerGene to Transform Gene Therapy Manufacturing Klotho Neurosciences, Inc. has achieved a pivotal milestone in its pursuit of innovative gene therapies by enterin…
Klotho Neurosciences Pursues Innovations in Longevity and Brain Health Klotho Neurosciences, Inc. is making significant strides in the biotechnology sector with its recent announcement regarding the e…
Klotho Neurosciences: Pioneering Longevity and Neurodegenerative Disease Solutions Klotho Neurosciences, Inc. focuses on developing innovative therapies aimed at combatting neurodegenerative diseases…
Klotho Neurosciences Partners with AAVnerGene to Revolutionize Gene Therapy for Neurological Diseases Klotho Neurosciences, Inc. has entered a strategic partnership with AAVnerGene Inc. to enhance its…
Klotho Neurosciences Validates Compliance with NASDAQ Requirements, Reinforcing Commitment to Neurodegenerative Disease Therapies Klotho Neurosciences, Inc. (NASDAQ: KLTO), a pioneering company focuse…
Klotho Neurosciences Secures NASDAQ Compliance Amidst Focus on Neurodegenerative Treatments Klotho Neurosciences, Inc. recently announces its compliance with NASDAQ listing requirements, receiving con…
Klotho Neurosciences Solidifies Position in Biogenetics with Compliance Announcement Klotho Neurosciences, Inc. is making strides in the biogenetics sector by confirming its compliance with NASDAQ lis…
Klotho Neurosciences Advances Gene Therapy for ALS: A Promising Breakthrough Klotho Neurosciences, Inc. is making significant strides in developing KLTO-202, an investigational gene therapy designed t…
Klotho Neurosciences Advances Gene Therapy Development for ALS Klotho Neurosciences, Inc. is making significant strides in the fight against amyotrophic lateral sclerosis (ALS) with the advancement of…
Klotho Neurosciences Advances Gene Therapy for ALS Treatment Klotho Neurosciences, Inc. is making significant strides in the field of gene therapy with its investigational treatment KLTO-202, specific…
Unlocking Longevity: The Klotho-Neuroscience Collaboration Klotho Neuroscience, Inc. forges a significant partnership with the Okinawa Research Center for Longevity Science (ORCLS) to investigate the…
Unlocking Longevity: Klotho Neuroscience Partners with Okinawa Research Center Klotho Neuroscience, Inc. (NASDAQ: KLTO) enters a promising partnership with the Okinawa Research Center for Longevity Sc…
Neurvati Neurosciences Welcomes Dr. Gail M. Farfel to Board Amid Pivotal Trial for Neurodevelopmental Disorders Neurvati Neurosciences, a clinical-stage biotechnology company dedicated to developing t…
Neurvati Neurosciences Enhances Leadership with Dr. Gail M. Farfel’s Appointment Neurvati Neurosciences, a clinical-stage biotechnology firm dedicated to developing therapies for neurological and psyc…
Neurvati Neurosciences Strengthens Leadership with Appointment of Dr. Gail M. Farfel Neurvati Neurosciences, a clinical-stage biotechnology firm dedicated to developing therapies for neurological and…